Session Details
[Poster]S2
Tue. Sep 16, 2025 6:30 PM - 8:00 PM JST
Tue. Sep 16, 2025 9:30 AM - 11:00 AM UTC
Tue. Sep 16, 2025 9:30 AM - 11:00 AM UTC
Poster
[P-S2-01]ON-LINE MONITORING OF 177Lu SEPARATION BY EXTRACTION CHROMATOGRAPHY
*Kenji Shirasaki1, Kohshin Washiyama2, Tomoo Yamamura3 (1. Institute for Radiation Science, The University of Osaka (Japan), 2. Advanced Clinical Research Center, Fukushima Global Medical Science Center, Fukushima Medical University (Japan), 3. Institute for Integrated Radiation and Nuclear Science, Kyoto University (Japan))
[P-S2-02]RECOVERY OF ASTATINE-211 WITH PURE WATER AFTER DRY DISTILLATION SEPARATION
*Kazuhiro Ooe1, Masashi Murakami2, Yukiyoshi Kon2, Atsushi Toyoshima2, Yoshifumi Shirakami2 (1. Radioisotope Research Center, Institute for Radiation Sciences, The University of Osaka (Japan), 2. Institute for Radiation Sciences, The University of Osaka (Japan))
[P-S2-03]Thin-layer chromatography for astatine solutions containing reducing agents
*Ichiro Nishinaka1, Kazuyuki Hashimoto2, Akihiko Yokoyama3 (1. Takasaki Institute for Advanced Quantum Science, National Institutes for Quantum Science and Technology (QST) (Japan), 2. Nuclear Science Research Institute, Japan Atomic Energy Institute (JAEA) (Japan), 3. College and Institute of Science and Engineering, Kanazawa University (Japan))
[P-S2-04*]Flow-Electrolytic Labeling of 211At for Radiopharmaceutical Synthesis in Targeted Alpha Therapy
*Akina Mitsukai1, Yoshihumi Shirakami2, Masashi Murakami2, Kazuki Kajiyama2, Sadaaki Kimura3, Atsushi Toyoshima2 (1. Graduate school of Science, the University of Osaka (Japan), 2. Institute for Radiation Sciences (Japan), 3. Alpha Fusion Inc. (Japan))
[P-S2-05]CHROMATOGRAPHIC ANALYSIS OF ASTATINE IN METHANOL SOLUTIONS TOWARD STANDARDIZATION OF THE QUALITY OF ASTATINE SUPPLY SOLUTION
*Shigeki Watanabe1, Masashi Murakami2, Ichiro Sasaki1, Kazuhiro Ooe2, Yukiyoshi Kon2, Tomoyuki Ohya3, Jun Ichinose3, Katsuyuki Minegishi3, Kotaro Nagatsu3, Atsushi Toyoshima2, Noriko S Ishioka1 (1. Takasaki Institute for Advanced Quantum Science, National Institutes for Quantum Science and Technology (Japan), 2. Institute for Radiation Sciences, The University of Osaka (Japan), 3. Institute for Quantum Medical Science, National Institute for Quantum Science and Technology (Japan))
[P-S2-06]CHROMATOGRAPHIC ANALYSIS OF ASTATINE IN AQUEOUS SOLUTIONS FOR STANDARDIZATION OF THE QUALITY OF ASTATINE SUPPLY SOLUTION
*Masashi Murakami1, Shigeki Watanabe2, Ichiro Sasaki2, Kazuhiro Ooe1, Yukiyoshi Kon1, Tomoyuki Ohya2, Jun Ichinose2, Katsuyuki Minegishi2, Kotaro Nagatsu2, Noriko S. Ishioka2, Atsushi Toyoshima1 (1. The University of Osaka (Japan), 2. National Institute for Quantum Science and Technology (Japan))
[P-S2-07*]SYNTHESIS AND CHARACTERIZATION OF STRONGLY PHOTOLUMINESENCE NITRIDOTECHNETIUM(V) AND RHENIUM(V) COMPLEXES
*Sodai Miyamoto1, Takashi Yoshimura2 (1. Department of Chemistry, Graduate School of Science, The University of Osaka (Japan), 2. Radioisotope Research Center, Institute for Radiation Science, The University of Osaka (Japan))
[P-S2-08*]SYNTHESIS OF CRYPTAND-BASED CHELATING LIGANDS FOR STABLE Pb(II) COMPLEXES IN NUCLEAR MEDICINE APPLICATIONS
*Eishun Kawagishi1, Kojiro Nagata2, Masashi Kaneko1, Hiroyuki Kazama1, Hiroki Aoto1, Haruka Maeda1, Terumi Yokoyama1, Yoshitaka Kasamatsu1 (1. Graduate School of Science, The University of Osaka (Japan), 2. Core Facility Center, The University of Osaka (Japan))
[P-S2-09]Synthesis of Lanthanum, Barium, and Actinuim Complexes with The 15-Membered Cyclic Ligand Having Phosphonate Arms
Kenshin Yamashita1, Kenta Hamasaki1, Kenji Shirasaki1, Takuya Yokokita2, Hidetoshi Kikunaga2, Kazuaki Tsukada2, Tatsuo Yajima3, *Takashi Yoshimura1 (1. The University of Osaka (Japan), 2. Tohoku University (Japan), 3. Kansai University (Japan))
[P-S2-10*]SYNTHESIS OF MACROCYCLIC 1,2-HYDROXYPYRIDINONE-BASE LIGAND FOR 227Th AND 89Zr RADIOPHARMACEUTICALS
*Terumi Yokoyama1, Hiroyuki Kazama1, Masashi Kaneko1, Kojiro Nagata2, Hiroki Aoto1, Haruka Maeda1, Eishun Kawagishi1, Yoshitaka Kasamatsu1 (1. Graduate School of Science, The University of Osaka (Japan), 2. Core Facility Center, The University of Osaka (Japan))
[P-S2-11*]SYNTHESIS AND PROPERTIES OF BARIUM, LANTHANUM, AND ACTINIUM COMPLEXES WITH THE 18-MEMBERED CYCLIC LIGAND WITH PYRIDINE PHOSPHONATE ARMS FOR RADIOPHARMACEUTICALS
*Kaseki Matsuda1, Kazuaki Baba1, Kojiro Nagata1, Kenji Shirasaki1, Takuya Yokokita2, Hidetoshi Kikunaga2, Kazukaki Tsukada2, Tatsuo Yajima3, Takashi Yoshimura1 (1. The University of Osaka (Japan), 2. Tohoku University (Japan), 3. Kansai University (Japan))
[P-S2-12]Development of an Imaging Probe Targeting Adrenal Aldosterone Synthase (CYP11B2)
*Hiroyuki Kimura1, Yusuke Yagi2, Riko Fuseda3, Takaaki Murakami4, Marina Omokawa5, Masakatsu Sone6, Hiroyuki Yasui3, Nobuya Inagaki4, Hideo Saji7 (1. Agency for Health, Safety and Environment, Kyoto University (Japan), 2. Department of Radiological Technology, Faculty of Medicinal Science, Kyoto University of Medical Science (Japan), 3. Laboratory of Analytical and Bioinorganic Chemistry, Division of Analytical and Physical Sciences, Kyoto Pharmaceutical University (Japan), 4. Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University Hospital (Japan), 5. Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University (Japan), 6. Department of Metabolism and Endocrinology, St. Marianna University School of Medicine (Japan), 7. Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University (Japan))
[P-S2-13]Improved in vivo stability of astatobenzoyl compounds by conjugating with D-oligopeptides
*Hiroyuki Suzuki1, Mutsuho Murata1, Kento Kannaka1, Souma Kitagawa1, Souta Tatusta1, Kazuhiro Takahashi2, Tomoya Uehara1 (1. Chiba University (Japan), 2. Fukushima Medical University (Japan))
[P-S2-14*]Analysis of cell death induced by short-lived alpha-emitting radionuclides
*Soichiro Magara1, Koki Mayusumi1, Erina Hilmayanti1, Kazuhiro Ooe2,3, Atsushi Toyoshima2,3, Koichi Fukase1,2,3, Kazuya Kabayama1,2,3 (1. Department of Chemistry, Graduate School of Science, The University of Osaka (Japan), 2. Forefront Research Center, Graduate School of Science, The University of Osaka (Japan), 3. Institute for Radiation Sciences, The University of Osaka (Japan))
[P-S2-15*]Structural Stability of Radio-activated Gold Compounds via Neutron Irradiation
*KAZUKI KAJIYAMA1, Akina Mitsukai1, Masashi Murakami2, Yoshifumi Shirakami2, Koichi Takamiya3, Jun Kataoka4, Atsushi Toyoshima2 (1. Graduate School of Science, The University of osaka (Japan), 2. Institute for Radiation Sciences, The University of Osaka (Japan), 3. Institute for Integrated Radiation and Nuclear Science, Kyoto University (Japan), 4. Research Institute for Science and Engineering, Waseda University (Japan))
[P-S2-16*]Development of Dual-Modality Microspheres Containing Gold Nanoparticles for Radioembolization: X-ray CT and SPECT-Visible
*Koino Nakamura1, Naoyuki Ukon2, Kohshin Washiyama2, Daichi Kuroiwa3, Hirofumi Sekino3, Hiroshi Ito3, Yoshitaka Takagai1 (1. Fukushima University (Japan), 2. Fukushima Medical University Advanced Clinical Research Center (Japan), 3. Fukushima Medical University School of Medicine (Japan))
[P-S2-17]Synthesis and evaluation of mPEG-modified [211At]AuNP(s): Towards the development of cancer treatment through intratumoral administration
*Yuichiro Kadonaga1, Hiroki Kato1, Hiroaki Shimamoto1, Xuhao Huang1, Erina Hilmayanti1, Kazuhiro Ooe1, Atsushi Shimoyama1, Kazuya Kabayama1, Xiaojie Yin1, Hiromitsu Haba1, Masashi Murakami1, Atsushi Toyoshima1, Koichi Fukase1 (1. The University of Osaka (Japan))
[P-S2-18*]Dose-Dependent Cytotoxic Profiling of Astatine-211 for Targeted Alpha Therapy
*Jumpei Ueno1, Koki Mayusumi1, Masayuki Takamatsu1,2, Atsushi Shimoyama1,2,3, Kazuya Kabayama1,2,3, Koichi Fukase1,2,3 (1. Department of Chemistry, Graduate School of Science, The University of Osaka (Japan), 2. Institute for Radiation Science, The University of Osaka (Japan), 3. Forefront Research Center, Graduate School of Science, The University of Osaka (Japan))
[P-S2-19]Dosimetry in targeted alpha particle therapy with astatine-211 in single cells using Al2O3:C, Mg-based fluorescent nuclear track detector
*Jun Hu1, Tamon Kusumoto1, Satoshi Kodaira1 (1. Institute for Radiological Sciences, National Institutes for Quantum Science and Technology (QST), Japan (Japan))
[P-S2-20*]Development of Astatine-Labeled Functional Proteins for Cancer Therapy
*Koki Mayusumi1, Kazuya Kabayama1,2,3, Kazuko Kaneda-Nakashima1,2,3, Junichi Takagi4, Hiroaki Suga5, Kazuhiro Ooe2,3, Atsushi Toyoshima2,3, Koichi Fukase1,2,3 (1. Dept. of Chem., Grad. Sch. of Sci., The University of Osaka (Japan), 2. FRC, Grad. Sch. of Sci., The University of Osaka (Japan), 3. Inst. for Radiation Sciences, The University of Osaka (Japan), 4. Inst. for Protein Research, The University of Osaka (Japan), 5. Grad. Sch. of Sci., The University of Tokyo (Japan))
[P-S2-21]Random and Site-Specific Conjugation of TCO to Anti-PD-L1 Monoclonal Antibodies for In Vitro Click Labeling: A Step Toward Pretargeted ImmunoPET Imaging Agents
*Feng-Yun Jimmy Huang1, Ruey-Jing Huang2, Ching-Wen Cheng1, Kuo-Ting Chen3 (1. Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology (Taiwan), 2. Department of Diagnostic Radiology, Hualien Armed Forces General Hospital (Taiwan), 3. Department of Chemistry, National Dong Hwa University (Taiwan))
[P-S2-22]SYNTHESIS AND EVALUATION OF ASTATINE-211-LABELED FAP-INHIBITOR RADIOPHARMACEUTICALS
*Masayuki Takamatsu1,2, Atsushi Shimoyama1,2, Ayaka Aso1, Taketo Toda1, Jumpei Ueno1, Koki Mayusumi1, Kazuya Kabayama2, Yuichiro Kadonaga2, Yoshifumi Shirakami2, Tadashi Watabe2,3, Taku Yoshiya4, Kazuhiro Ooe2, Atsushi Toyoshima2, Hiromitsu Haba5, Jens Cardinale6, Frederik Lars Giesel6, Kazuko Kaneda Nakashima2, Koichi Fukase1,2 (1. Grad. Sch. Sci., The Univ. of Osaka (Japan), 2. IRS, Osaka Univ., The Univ. of Osaka (Japan), 3. Grad. Sch. Med., The Univ. of Osaka (Japan), 4. Peptide Institute, Inc. (Japan), 5. RIKEN (Japan), 6. University Hospital Düsseldorf (Germany))
[P-S2-23*]Development of Novel Radioimmunotherapeutic AgentsTargeting Epithelial Cell Adhesion Molecule
*Sato Oshige1, Takumi Iwasawa2, Marina Omokawa3, Yoji Kitamura4, Takashi Kozaka4, Yusuke Yagi5, Takiko Daikoku6, Kazunori Kato2, Hiroyuki Kimura7 (1. Kanazawa University (Japan), 2. Toyo University (Japan), 3. Okayama University (Japan), 4. Division of Animal Disease Model, Kanazawa University (Japan), 5. Kyoto University of Medical Science (Japan), 6. Division of Animal Disease Model, Research Center for Experimental Modeling of Human Disease, Kanazawa University (Japan), 7. Kyoto University (Japan))
[P-S2-24]Activities of Alpha-tergeted Therapy using astatine-211 at Osaka University in Japan
*Kazuya Kabayama1, Atsushi Toyoshima1, Koichi Fukase1 (1. Institute for Radiation Sciences, University of Osaka (Japan))
[P-S2-25]Efforts by the Japanese Astatine Community toward clinical application of alpha emitter 211At
*Kohshin Washiyama1, Takashi Nakano2, Mikako Ogawa3, Hiroki Kanda2, Kazuya Taki4 (1. Fukushima Medical University (Japan), 2. The University of Osaka (Japan), 3. Hokkaido University (Japan), 4. Sumitomo Heavy Industries, Ltd. (Japan))